John Nolan

974 total citations
28 papers, 787 citations indexed

About

John Nolan is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, John Nolan has authored 28 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Organic Chemistry. Recurrent topics in John Nolan's work include Neuroblastoma Research and Treatments (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). John Nolan is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). John Nolan collaborates with scholars based in United Kingdom, Ireland and United States. John Nolan's co-authors include Matthew A. Naylor, Ian J. Stratford, Olga Piskareva, Michael R.L. Stratford, Peter D. Davis, Gillian M. Tozer, David J. Chaplin, Graeme J. Dougherty, Susan Galbraith and Angela Holder and has published in prestigious journals such as Chemical Communications, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

John Nolan

26 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Nolan United Kingdom 16 409 277 169 148 116 28 787
Sara A. Fitzsimmons United Kingdom 7 281 0.7× 207 0.7× 88 0.5× 77 0.5× 25 0.2× 8 555
V.Kate Hirst United States 9 307 0.8× 409 1.5× 98 0.6× 135 0.9× 40 0.3× 14 787
Tiefeng Jin China 24 900 2.2× 318 1.1× 75 0.4× 275 1.9× 44 0.4× 65 1.3k
Masashi Aonuma Japan 11 1.2k 2.8× 122 0.4× 128 0.8× 875 5.9× 78 0.7× 14 1.5k
Elena Porcù Italy 19 432 1.1× 117 0.4× 284 1.7× 156 1.1× 25 0.2× 39 901
Rachel Cowen United Kingdom 15 333 0.8× 284 1.0× 35 0.2× 134 0.9× 31 0.3× 21 585
M.F. Dennis United Kingdom 13 376 0.9× 242 0.9× 101 0.6× 153 1.0× 18 0.2× 24 717
Raymond S. Marshall Canada 7 302 0.7× 293 1.1× 40 0.2× 85 0.6× 13 0.1× 7 524
Heekyoung Yang South Korea 16 535 1.3× 222 0.8× 36 0.2× 261 1.8× 35 0.3× 29 967
Rosemary C. McFall United States 15 374 0.9× 140 0.5× 239 1.4× 170 1.1× 20 0.2× 23 880

Countries citing papers authored by John Nolan

Since Specialization
Citations

This map shows the geographic impact of John Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Nolan more than expected).

Fields of papers citing papers by John Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Nolan. The network helps show where John Nolan may publish in the future.

Co-authorship network of co-authors of John Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of John Nolan. A scholar is included among the top collaborators of John Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Nolan. John Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, Ellen, John Nolan, & Olga Piskareva. (2022). Assessment of Basic Biological Functions Exerted by miRNAs. Methods in molecular biology. 2595. 115–122.
2.
Nolan, John, Manuela Salvucci, Steven Carberry, et al.. (2020). A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro. Frontiers in Cell and Developmental Biology. 8. 559553–559553. 20 indexed citations
3.
Langella, Emma, Ida Autiero, John Nolan, et al.. (2019). A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a. Bioorganic Chemistry. 91. 103165–103165. 15 indexed citations
4.
Curtin, Caroline M., John Nolan, Ronald A. Conlon, et al.. (2018). A physiologically relevant 3D collagen-based scaffold–neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models. Acta Biomaterialia. 70. 84–97. 49 indexed citations
5.
Nolan, John, Raymond L. Stallings, & Olga Piskareva. (2016). Assessment of Basic Biological Functions Exerted by miRNAs. Methods in molecular biology. 1509. 11–16. 3 indexed citations
6.
Piskareva, Olga, Harry Harvey, John Nolan, et al.. (2015). The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Letters. 364(2). 142–155. 71 indexed citations
7.
Davis, Peter D., Graeme J. Dougherty, David C. Blakey, et al.. (2002). ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.. Oxford University Research Archive (ORA) (University of Oxford). 62(24). 7247–53. 200 indexed citations
8.
9.
Everett, Steven A., Matthew A. Naylor, Stephen Moore, et al.. (1999). Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones. Bioorganic & Medicinal Chemistry Letters. 9(1). 113–118. 20 indexed citations
10.
Naylor, Matthew A., John Nolan, Peter O’Neill, et al.. (1994). Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity. International Journal of Radiation Oncology*Biology*Physics. 29(2). 333–337. 6 indexed citations
11.
Path, F.R.C., et al.. (1992). Retention of misonidazole in normal and malignant tissues: Interplay of hypoxia and reductases. International Journal of Radiation Oncology*Biology*Physics. 22(4). 655–659. 18 indexed citations
12.
Cole, Soren, Ian J. Stratford, John Nolan, et al.. (1991). Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice. International Journal of Radiation Oncology*Biology*Physics. 21(2). 387–395. 15 indexed citations
13.
Nolan, John, et al.. (1990). Distribution of pimonidazole and RSU 1069 in tumour and normal tissues. British Journal of Cancer. 62(6). 915–918. 19 indexed citations
14.
Nolan, John, et al.. (1990). Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse. International Journal of Radiation Oncology*Biology*Physics. 18(2). 347–351. 15 indexed citations
15.
16.
Path, F.R.C., et al.. (1989). Autoradiographic study of tritium-labeled misonidazole in the mouse. International Journal of Radiation Oncology*Biology*Physics. 16(4). 953–956. 13 indexed citations
17.
Nolan, John, et al.. (1989). Microscopic distribution of misonidazole in mouse tissues. British Journal of Cancer. 59(1). 12–16. 17 indexed citations
18.
Stratford, Ian J., et al.. (1988). Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. British Journal of Cancer. 58(2). 122–127. 55 indexed citations
19.
Nolan, John & K. A. Hartman. (1975). The in vitro synthesis of lysozyme, total proteins, and polyphenylalanine by ribosomes containing hydrolyzed ribonucleic acid. Archives of Biochemistry and Biophysics. 166(1). 251–257.
20.
Hartman, K. A., et al.. (1971). The dependence of the rate of RNase A catalyzed hydrolysis of ribosomes and rRNA on the concentration of magnesium and ammonium ions. Biochemical and Biophysical Research Communications. 45(5). 1307–1311. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara A. Fitzsimmons Breakdown of academic impact, for papers by V.Kate Hirst Breakdown of academic impact, for papers by Tiefeng Jin Breakdown of academic impact, for papers by Masashi Aonuma Breakdown of academic impact, for papers by Elena Porcù Breakdown of academic impact, for papers by Rachel Cowen Breakdown of academic impact, for papers by M.F. Dennis Breakdown of academic impact, for papers by Raymond S. Marshall Breakdown of academic impact, for papers by Heekyoung Yang Breakdown of academic impact, for papers by Rosemary C. McFall
Rankless by CCL
2026